10100
Previously , fidarestat was found to be safe in phase III trials for diabetic neuropathy and , consistent with its low in vivo side effects , was highly selective for aldose reductase ( AR or AKR1B1 ) versus aldehyde reductase ( AKR1A1 ) .
 Chemical: fidarestat; Chemical: aldose; Chemical: aldehyde
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: fidarestat; Chemical: aldose; Chemical: aldehyde